FDA Inspection 1226482 — Abbott Diabetes Care, Inc.

Abbott Diabetes Care, Inc. — FEI 3002803444

The FDA completed an inspection of Abbott Diabetes Care, Inc. on November 16, 2023 in Alameda, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 16, 2023
Fiscal Year
2024
Product Type
Devices
Project Area
Compliance: Devices
Location
Alameda, CA (United States)